← Open Payments lookup

TAMRA DILLON: Open Payments

NPI 1497378657 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$712 in 18 payments from 6 companies in 2025. Trend: 2023 $1,082 · 2024 $1,056 · 2025 $712

Food & beverage: $712
CompanyPaymentsAmount
Axsome Therapeutics, Inc.12$531
E.R. Squibb & Sons, L.L.C.1$90
Alkermes, Inc.2$39
ABBVIE INC.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$16
Takeda Pharmaceuticals U.S.A., Inc.1$14

Products named: Auvelity, COBENFY, ARISTADA, VRAYLAR, CAPLYTA, TRINTELLIX.

Industry payments across WA — which companies pay providers there.